ID4 methylation patterns in childhood T line and B line lymphocytic leukemia

Chinese Journal of Contemporary Pediatrics

Volumn 12, Issue 12, 2010, Pages 940-942

  Hu, Hong Bo ^a   Hu, Qun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Child; Inhibitor of DNA binding 4; Leukemia; Methylation

Indexed keywords

INHIBITOR OF DNA BINDING 4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; INHIBITOR OF DIFFERENTIATION PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; HUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; STATISTICAL ANALYSIS; T CELL LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; GENETICS;

DNA METHYLATION; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC;

EID: 78651268874     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Li Y, Nagai H, Ohno T, Yuge M, Hatano S, Ito E, et al. Aberrant DNA methylation of p57 (KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype[J]. Blood, 2002, 100(7): 2572-2577.
2. Pagliuca A, Cannada-Bartoli P, Lania L. A role for Sp and helix-loop-helix transcription factors in the regulation of the human Id4 gene promoter activity[J]. J Biol Chem, 1998, 273(13): 7668-7674.
3. Uhm KO, Lee ES, Lee YM, Kim HS, Park YN, Park SH. Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma[J]. Oncol Res, 2008, 17(4): 151-157.
4. Borinstein SC, Conerly M, Dzieciatkowski S, Biswas S, Washington MK, Trobridge P, et al. Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model[J]. Mol Carcinog, 2010, 49(1): 94-103.
5. Tsunoda S, Smith E, De Young NJ, Wang X, Tian ZQ, Liu JF, et al. Methylation of CLDN6, FBN2, RBP1, RBP4, TFP12, and TMEFF2 in esophageal squamous cell carcinoma[J]. Oncol Rep, 2009, 21(4): 1067-1073.
6. Roldán G, Delgado L, Musé LM. Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer[J]. Cancer Biol Ther, 2006, 5(5): 505-510.
7. Noetzel E, Veeck J, Niederacher D, Galm O, Horn F, Hartmann A, et al. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer[J]. BMC Cancer, 2008, 8: 154.
8. Yuen HF, Chua CW, Chan YP, Wong YC, Wang X, Chan KW. Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases[J]. Mod Pathol, 2006, 19(7): 931-941.
9. Asirvatham AJ, Schmidt MA, Chaudhary J. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells[J]. Prostate, 2006, 66(9): 921-935. (Pubitemid 43849591)
10. Carey JP, Asirvatham AJ, Galm O, Ghogomu TA, Chaudhary J. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer[J]. BMC Cancer, 2009, 9: 173.
11. Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu YZ, et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia[J]. Nat Genet, 2005, 37(3): 265-274.
12. Hagiwara K, Nagai H, Li Y, Ohashi H, Hotta T, Saito H. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma[J]. J Clin Exp Hematop, 2007, 47(1): 15-18.
13. Uhm KO, Lee ES, Lee YM, Park JS, Kim SJ, Kim BS, et al. Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia[J]. J Korean Med Sci, 2009, 24(3): 493-497.